Table 1.
Trend in patient’s blood investigations
|
|
Day 1
|
Day 2
|
Day 3
|
Day 4
|
Day 5
|
Day 7
|
Day 13
|
Day 17
|
Day 24
|
Day 60
|
Day 135
|
| Renal function | |||||||||||
| Serum creatinine (μmol/L) | 1101 | 680 | 659 | 495 | 340 | 328 | 208 | 177 | 127 | 99 | |
| Serum urea (mmol/L) | 38.1 | 23.1 | 27.1 | 22.0 | 14.5 | 25.2 | 17.4 | 10.6 | 12.4 | 6.2 | |
| Electrolytes | |||||||||||
| Sodium (mmol/L) | 134 | 142 | 146 | 147 | 137 | 135 | 136 | 138 | 140 | 144 | |
| Potassium (mmol/L) | 4.4 | 3.5 | 3.5 | 3.1 | 4.0 | 4.3 | 4.0 | 4.1 | 3.8 | 3.9 | |
| Chloride (mmol/L) | 101 | 105 | 102 | 100 | 98 | 101 | 102 | 105 | 108 | 110 | |
| Bicarbonate (mmol/L) | 15.9 | 22.8 | 26.8 | 31.1 | 24.6 | 28.3 | 23.7 | 24.6 | 23.5 | 24.9 | |
| Magnesium (mmol/L) | 0.91 | ||||||||||
| Liver function | |||||||||||
| Total protein (g/L) | 60 | 76 | |||||||||
| Serum albumin (g/L) | 32 | 41 | |||||||||
| Total bilirubin (mmol/L) | 07 | 09 | |||||||||
| Alkaline phosphatase (U/L) | 58 | 65 | |||||||||
| Alkaline transaminase (U/L) | 57 | 17 | |||||||||
| Routine tests | |||||||||||
| White blood cells (× 109/L) | 9.33 | 10.25 | 9.89 | ||||||||
| Neutrophil (%) | 78.8 | 74.6 | 74.1 | ||||||||
| Lymphocytes (%) | 11.1 | 11.6 | 15.9 | ||||||||
| Hemoglobin (g/dL) | 12.3 | 13.8 | 14.1 | ||||||||
| Platelet count (× 109/L) | 208 | 307 | 281 | ||||||||
| Coagulation | |||||||||||
| APTT (secs) | 27.0 | 28.5 | |||||||||
| Prothrombin time (secs) | 11.2 | 11.4 | |||||||||
| Other indicators | |||||||||||
| Creatine kinase (U/L) | 7224 | 4755 | 2863 | 754 | 84 | 84 | |||||
| PTH (pg/mL) | 11.0 | ||||||||||
| Urine creatinine (μmol/L) | 5233 | 3862 | 7747 | 8035 |
APTT: Activated partial thromboplastin time; PTH: Parathyroid hormone.